Patents by Inventor Jared Carlson-Stevermer

Jared Carlson-Stevermer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11884918
    Abstract: Provided herein are polynucleotides comprising sequence configured to bind to a CRISPR effector protein. Modulation of one or more modifications of the polynucleotides can be used to tune the activity of CRISPR effector proteins complexed with the polynucleotides.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: January 30, 2024
    Assignee: Synthego Corporation
    Inventors: Reed Kelso, Jared Carlson-Stevermer, Sahil Joshi, Travis Maures, Anastasia Kadina, John Andrew Walker, II
  • Publication number: 20220073912
    Abstract: Provided herein are polynucleotides comprising sequence configured to bind to a CRISPR effector protein. Modulation of one or more modifications of the polynucleotides can be used to tune the activity of CRISPR effector proteins complexed with the polynucleotides.
    Type: Application
    Filed: July 23, 2021
    Publication date: March 10, 2022
    Inventors: Reed Kelso, Jared Carlson-Stevermer, Sahil Joshi, Travis Maures, Anastasia Kadina, John Andrew Walker, II
  • Publication number: 20220056436
    Abstract: Provided herein are polynucleotides and CRISPR effector proteins configured to be covalently bound together in a CRISPR complex. The polynucleotides can be further modified to modulate the activity of the CRISPR complex. Modification of the polynucleotide and CRISPR effector protein can be used to improve the efficacy of target binding and/or cleavage.
    Type: Application
    Filed: July 23, 2021
    Publication date: February 24, 2022
    Inventors: Travis Maures, Jared Carlson-Stevermer, Sahil Joshi, Reed Kelso, Anastasia Kadina, John Andrew Walker, II